Navigation Links
The 2011 Mycoplasma Diagnostics Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country
Date:11/17/2011

NEW YORK, Nov. 17, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Test-Volume-Sales-Forecasts-and-Supplier-Shares-by-Country.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Diagnostics title='The 2011 Mycoplasma Diagnostics Market: US, Europe, Japan

Test Volume, Sales Forecasts and Supplier Shares by Country'>The 2011 Mycoplasma Diagnostics Market: US, Europe, Japan

Test Volume, Sales Forecasts and Supplier Shares by Country

http://www.reportlinker.com/p0444725/The-2011-Mycoplasma-Diagnostics-Market-US-Europe-Japan

Test-Volume-Sales-Forecasts-and-Supplier-Shares-by-Country.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Diagnostics

The report presents a detailed analysis of the Mycoplasma diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Mycoplasma definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:

     - Hospitals

     - Commercial/Private Labs

     - Physician Offices

- Public Health Labs

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Mycoplasma tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 202 pages and 15 tables

Table of Contents

I. Introduction

II. Worldwide Market and Technology Overview

A. Background

Ureaplasma Urealyticum & Mycoplasma Hominis

B. Diagnostic Tests

C. Vaccines and Drugs

D. Emerging Diagnostic Technologies

1. DNA Probes

a. Technology Overview

b. Amplification Methods

Polymerase Chain Reaction

Robotics

Temperature Cyclers

PCR Variations

Immuno-PCR

QC-PCR

DAP-PCR

Ligase Chain Reaction

Branched DNA

Q-Beta Replicase

Nucleic-Acid Sequence-Based

Strand Displacement Activation

Self-Sustained Sequence Replicase

2. Monoclonal Antibodies

3. Immunoassays

a. Technological Principle

b. Enzyme Immunoassays (EIA)

Overview

ELISA

Dot Immunobinding Assays

Capillary Immunoassays

Particle-Membrane Capture Immunoassays

Enzyme Amplification

c. Fluorescent Immunoassays

Fluorescence Polarization

Time-Resolved Pulse Fluorescence

d. Luminescence

Chemiluminescence

Bioluminescence

e. Latex Agglutination

f. Immunoprecipitation

4. Differential Light Scattering

5. Microcomputers and Automation

6. Artificial Intelligence

7. Liposomes

8. Flow Cytometry

9. Chromatography

10. MRI

11. Gel Microdroplets

12. Other

III. France: Market Size, Growth and Major Suppliers' Sales and Market Shares

IV. Germany: Market Size, Growth and Major Suppliers' Sales and Market Shares

V. Italy: Market Size, Growth and Major Suppliers' Sales and Market Shares

VI. Japan: Market Size, Growth and Major Suppliers' Sales and Market Shares

VII. Spain: Market Size, Growth and Major Suppliers' Sales and Market Shares

VIII. UK: Market Size, Growth and Major Suppliers' Sales and Market Shares

IX. USA: Market Size, Growth and Major Suppliers' Sales and Market Shares

W. Alternative Market Penetration Strategies

A. Internal Development

B. Collaborative Arrangements

C. University Contracts

D. Distribution Strategies for Decentralized Testing Markets

1. Marketing Approaches

2. Product Complexity

3. Customer Preference

4. Established Suppliers

5. Emerging Suppliers

6. Major Types of Distributors

7. Market Segmentation

XI. Potential Market Entry Barriers and Risks

A. Market Maturity

B. Cost Containment

C. Competition

D. Technological Edge and Limitations

E. Patent Protection

F. Regulatory Constraints

G. Decentralized Testing Market Challenges

XII. Competitive Assessments

Abbott

Affymetrix

Applera

Beckman Coulter

Becton Dickinson

Binding Site

Biomerica

Biokit

bioMerieux

Bio-Rad

Biotrol

Biosite

Biotest

Caliper Technologies

Cepheid

Chemicon

Daiichi

DiaSorin

Diagast

Diamedix

Digene

Eiken

Enzo Biochem

Fujirebio

GenBio

Gene-Tec

Hemagen

Immunetics

Innogenetics

Inverness

J&J

Meridian

Nanogen

Nissui

Olympus

Provalis

Roche

Saliva Diagnostic

SeraCare

Siemens

Third Wave Technologies

Thermo Fisher

Tosho

Trinity Biotech

Tropix

Wampole Labs

Zenith

Zeus

List of Tables

Major Companies Developing or Marketing Mycoplasma Tests

France

Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment

France

Mycoplasma Testing Market Diagnostics Sales by Major Supplier

Germany

Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment

Germany

Mycoplasma Testing Market Diagnostics Sales by Major Supplier

Italy

Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment

Italy

Mycoplasma Testing Market Diagnostics Sales by Major Supplier

Japan

Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment

Japan

Mycoplasma Testing Market Diagnostics Sales by Major Supplier

Spain

Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment

Spain

Mycoplasma Testing Market Diagnostics Sales by Major Supplier

U.K.

Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment

U.K.

Mycoplasma Testing Market Diagnostics Sales by Major Supplier

U.S.A.

Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment

U.S.A.

Mycoplasma Testing Market Diagnostics Sales by Major Supplier

To order this report:

:

Test-Volume-Sales-Forecasts-and-Supplier-Shares-by-Country.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Diagnostics title='The 2011 Mycoplasma Diagnostics Market: US, Europe, Japan

Test Volume, Sales Forecasts and Supplier Shares by Country'>The 2011 Mycoplasma Diagnostics Market: US, Europe, Japan

Test Volume, Sales Forecasts and Supplier Shares by Country

More  Market Research Report

Check our  Real Time Industry Data

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New White Paper Examines Advanced Mycoplasma Tests - How Real-Time PCR Analysis Helps Save Time and Money for Biopharmaceutical Manufacturers
2. Clongen Laboratories Announces Formation of Separate Clinical Diagnostics and Contract Research Divisions
3. Quest Diagnostics to Speak at the Lazard Capital Markets 8th Annual Healthcare Conference
4. Augurix Diagnostics Receives the 2011 Debiopharm /Valais Award for its Point-of-care Diagnostic Test for the Early Detection of Celiac Disease
5. Quest Diagnostics Announces Launch of Simplexa™ Direct Test for Influenza and Respiratory Viruses in Europe
6. Life Technologies Signs Agreement with GlaxoSmithKline Biologicals S.A., Seeking Expanded Use of Platform Technologies into Companion Diagnostics
7. Quest Diagnostics to Release Third Quarter 2011 Financial Results
8. Medco, Quest Diagnostics Personalized Medicine Study Yields Additional Clues about Patient Engagement
9. Distinguished Speaker Dr. Elizabeth Mansfield Joins IVD Technology for Upcoming Webcast: The Regulation of Companion Diagnostics: Current Status and Updates
10. Key Pharma Diagnostics and Life Sciences Industry Expertise Added to Board of Directors of Modern Mobility Aids, Inc. (MDRM.OB)
11. Hydrocodone and Oxycodones Lead U.S. General Workforce Positives, Outranked Only by Marijuana, According to Quest Diagnostics Drug Testing Index™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016  In a startling report released today, ... residents by lacking a comprehensive, proven plan to eliminate prescription opioid ... ranking of how states are tackling the worst drug crisis in ... states – Kentucky , New Mexico ... . Of the 28 failing states, three – ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... Calif. , June 23, 2016 ... CST on Thursday, July 7, 2016 , , , , ... ) , , , , EXPERT PANELISTS:  , , ... Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar ... The global pharmaceutical industry is witnessing an exceptional ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
Breaking Medicine News(10 mins):